| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d829cb037f57d06c66530b3a71d9b709 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-1384
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0696 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
| filingDate |
2014-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e04910b4a3fe4c06f7332153b940c700
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_629f50b6b2bc9c20b3d855183e125252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_016cf67b1cc0cf07f416945b9c550cbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dc84f1ef041bf8d9e4d767cb45ddad8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4678e83a81c8d57299474509a6923e77 |
| publicationDate |
2015-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015190636-A1 |
| titleOfInvention |
Method for manufacturing induced pluripotent stem cells from adipose-derived mesenchymal stem cells and induced pluripotent stem cells manufactured by same method |
| abstract |
The present invention relates to a medium composition for reprogramming induced pluripotent stem cells, containing an Ecklonia cava extract. Also, the present invention relates to a method for manufacturing induced pluripotent stem cells by using the medium composition. When the medium composition according to the present invention is used, induced pluripotent stem cells can be efficiently produced using adipose-derived mesenchymal stem cells safely and easily. The manufactured pluripotent stem cells are differentiable into various cells, and thus can be favorably used as a cell therapeutic agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017114328-A1 |
| priorityDate |
2014-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |